Aims of this study: This study evaluated whether human cavernosal myo®broblasts in cell culture is a viable model for the study of the role of oxygen free radicals in the production of collagen types I and III, as observed in Peyronie's disease. Method: Human cavernosal cells in primary culture were incubated with 3 H-proline in the absence or presence of (i) glyceraldehyde; (ii) a-tocopherol (vitamin E); (iii) a combination of the two; or (iv) gamma interferon alone or in combination with glyceraldehyde. Collagen production was monitored after precipitation by speci®c monoclonal antibody and quantitated using a scintillation counter. Results: Collagen type III was stimulated to higher than baseline values after doses of 10 and 100 mM glyceraldehyde was added and showed suppression of stimulation with incorporation of a-tocopherol. There was a 40% increase in collagen type III production as compared to baseline values in glyceraldehyde-treated cells. Collagen type I showed no consistent stimulation or suppression. In glyceraldehyde-stimulated transformed cavernosal cells, a-tocopherol treatment caused a 10 ± 60% decrease in collagen type I and III production. With the addition of 100 000 IUaml gamma interferon, a signi®cant reduction of both collagen types I and III was observed. Conclusions: The generation of oxygen radicals is associated with the stimulation of collagen production in cavernosal cells. Transformed ®broblasts from cavernosal cells in culture can be utilized to explore possible etiologies of Peyronie's disease and to further evaluate potential medical therapies for this pathological condition.
Introduction
Peyronie's disease is an idiopathic, localized connective tissue disorder of the penis which involves the tunica albuginea of the corpus cavernosum and the adjacent areolar space. The tunica albuginea plays an important role in the mechanism of erection and is composed mainly of collagen bundles and elastic ®bers. The severity of the disease can be identi®ed by the presence of a palpable plaque in the¯accid state and signi®cant bend with or without pain during an erection. The penile plaques of Peyronie's disease are mainly composed of collagen. Pervious studies demonstrated this collagen to be predominantly type I and type III collagen ®bers. 1 Somers et al 1 examined
Peyronie's plaques and found that the collagen content, as a percentage of total protein in penile tissue, increased from 47% in men without Peyronie's to 68% in patients with Peyronie's disease.
Many theories have been proposed as to the origin of Peyronie's disease, however most authorities postulate that this condition is an autoimmune response to vascular trauma. 2 Investigation into the etiology of Peyronie's disease has focused on in¯am-matory reactions characterized by lymphocytic and plasmacytic in®ltration of the tunica albuginea which ultimately causes changes in collagen end elastic ®bers resulting in ®brosis. Peyronie's plaques typically form a loose areolar connective tissue sleeve that separates the corpus cavernosum from the tunica albuginea. In the early stages of this condition (usually less than three months), this sleeve contains a perivascular lymphocytic and plasmacytic in¯am-matory cellular in®ltrate. After this early in¯amma-tory phase, progression to ®brosis occurs, leading to a thickened connective tissue plaque, with possible calci®cation. 3 Electromicrographic evaluation of these plaques con®rms a vasculitis in the tunica albuginea associated with mast cells, further suggesting the role of in¯ammation. 4 Various chronic disease processes are characterized by progressive alterations of connective tissue resulting in ®brosis. Oxidative reactions are often associated with ®brogenesis, and evidence in the literature supports the role of oxidative stress and the stimulation of reactive oxygen species in the pathogenesis of this type of disease. 5, 6 One result of ®brogenesis is the increased synthesis of collagen. In 1993, Schellenberg et al 7 postulated that free radicals were involved in the pathogenesis of Peyronie's disease. They reasoned that because early lesions involve perivascular in®ltrates of lymphocytes, monocytes, and neutrophils, the mechanism of plaque ®brosis probably resulted from injury and an ensuing in¯ammatory process. Because of the complexity and variability of evaluating such interactions in vivo, the role of oxygen free radicals in the etiology of ®brotic Peyronie's plaques can be investigated using in vitro models. Previous reports have characterized the cell density andaor serum concentration on the amount of gene expression of collagen biosynthesis in vascular smooth muscle cells and ®broblast cultures. 8 ± 10 However, little if anything is known about the effects of oxygen free radicals on transformed ®broblasts from human cavernosal cells in vitro. Therefore, our study was based on the hypothesis that oxygen free radicals are generated during in¯ammation and can precipitate collagen formation in transformed ®broblasts from human cavernosal cells in culture.
Materials and methods
During implantation of penile prostheses, samples (2 ± 4 mm 3 ) of cavernosal tissue were obtained from patients with and without Peyronie's disease, grown in tissue culture, and characterized as described elsewhere. 11, 12 The tissue explants were grown as a primary culture using DMEM (Dulbecco's modi®ed Eagle's medium) until 90% con¯uency was reached. The cells were then harvested and placed into culture¯asks for serial passage. At the sixth passage, cells that were grown in high serum concentration (20% fetal bovine serum) medium normally transformed into ®broblasts, and their identity was con®rmed by light microscopy, immunohistochemistry, and electron microscopy. 11, 12 Growth arrest of these cells was achieved by incubation in Libby's medium for 18 ± 24 h. 13 The cells were then trypsinized, washed in Hank's Buffer, and transferred to 16-well culture plates for further growth in absence and presence of a test agent. Total cell count and viability were also determined simultaneously using an aliquot (2 ml cell suspension) incubated with 0.2 ml of 0.4% trypan blue. Nonviable cells stained blue.
Collagen stimulation
An aliquot of approximately 100 000 cells was placed into each of 16 wells of a microtiter plate. Collagen production was carried out in tissue culture by adding (a) an oxygen radical stimulant, L-glyceraldehyde (10 mM); (b) an oxygen radical scavenger, a-tocopherol (2.5 mM); or (c) a combination of the two. 14, 15 This dose selection was based upon our initial trial with L-glyceraldehyde at 0 ± 100 mM concentrations. In another experiment, gamma interferon (gIFN) at a concentration of 100 000 IUaml was used to test its effect on collagen production. In all wells, 50 m Ci (50 ml) of 3 H-proline (speci®c activity of 93 Ciammol) (Amersham, Arlington Heights, IL) was added and further incubated at 37
C with 4 ± 5% CO 2 and 95% humidity. All experiments were run in quadruplicate.
Immunoprecipitation
After 16 ± 24 h incubation, the cells and culture medium were homogenized and the homogenate (approximately 300 ml) incubated for 30 min with 50 ml of 10% sepharose CL4B and 50 ml of normal rabbit IgG. After 30 min, the medium was centrifuged and the supernatant containing the collagen decanted. Meanwhile, anti-human collagen type I and type III (Chemicon, Temecula, CA) monoclonal antibody (1 : 50 dilution) were prepared with a 10% solution of sepharose CL4B (Pharmacia) and placed at 4 C for 4 h as previously described. 16 This antihuman collagen antibody I or III mixture was then added to individual aliquots, vortexed, and incubated at 4 C for 12 ± 16 h. Each sample was centrifuged at 7000 rpm, and the pellets (collagen precipitates) washed twice with sodium phosphate binding buffer at pH 7.4. The washed pellets (containing the newly synthesized collagen) were suspended in 100 ml of sodium phosphate buffer and mixed with 3 ml of scintillation cocktail. The radioactivity (disintegrations per minute) was counted in a Beckman LS 7800 scintillation counter.
Results
Cavernosal cells in primary culture from tissues obtained from different patients demonstrated individual variation in regard to the type and amount of collagen produced. Of the six patient samples, ®ve showed stimulation of collagen type III, with four of these samples coming from patients with a diagnosis of Peyronie's disease as summarized in Table 1 . In additon, three of these ®ve patients also
showed stimulation of collagen type I (Table 1) . Samples from one patient demonstrated only increased collagen type I production. Because of the wide variation in baseline production of collagen as measured in disintegrations per minute, for comparison, absolute levels of collagen production from one patient sample to another are expressed as a percentage of each sample's control, where control values are taken to be 100% for that particular experiment. Figure 1 shows a dose-dependent stimulant of collagen, especially Type III, over control. Collagen type III was stimulated to greater than baseline with 10 and 100 mM glyceraldehyde and showed suppression of stimulation when atocopherol was added. The effects of glyceraldehyde and a-tocopherol (Vitamin E) on collagen production in cavernosal cells are summarized in Figure 2 . All samples that had stimulation of collagen production with the addition of glyceraldehyde also demonstrated suppression of stimulation when a-tocopherol was added. This suppression varies from 10 ± 60% depending upon patient sample. There was a 40% increase in collagen type III production as compared to baseline in glyceraldehyde-treated cells. Some samples, when compared with control samples, showed a decrease in baseline collagen production solely with a-tocopherol administration. This decrease ranged from 0 ± 50%.
The effect of gamma interferon on collagen production is summarized in Figure 3 . Gamma interferon exhibited a strong suppressant effect on collagen production in cavernosal cells. Furthermore, gamma interferon showed a stronger suppressant effect compared to that produced by atocopherol for collagen type III.
Discussion
The etiology of Peyronie's disease is poorly understood. Trauma, vitamin de®ciencies, and a genetic predisposition for senescence of tissue elasticity or decreased expression of scavenger enzymes are Collagen production in an in vitro model for Peyronie's disease SK Ahuja et al some of the purported causes. 7, 17 Our poor understanding of this disease is highlighted by the range of therapies available: from oral antioxidant vitamins to intralesional injection of various substances to surgical reconstruction. 18 ± 21 Chilton et al 22 in their study of 408 patients, reported on many causes; however, 33% of these cases were still classi®ed as idiopathic. Most authorities agree that there is an in¯amma-tory reaction associated with the formation of Peyronie's plaques as reported by Smith. 3 Oxidative stress is associated with an increased rate of cellular damage induced by reactive oxygen species. Various stress-related conditions, such as physical injury or trauma, can enhance the oxidative process and cause cell damage. Reactive oxygen species have been implicated in a number of disease states, ranging from arthritis and connective tissue disorders, such as ®brosis, to carcinogenesis and infertility. 23, 24 Based on the tissue disruption, microvascular injury, and ®broblast proliferation, Schellenberg and colleagues suggested that oxygen radicals were likely involved in many cases of Peyronie's disease. 7 We hypothesized that the corpus cavernosum of a Peyronie's patient, on stimulation by oxygen radicals, will demonstrate increased collagen production, while those without Peyronie's disease may show minimal or no increase in baseline collagen production. Somers et al 1 reported that collagen types I and III are predominantly found in Peyronie's plaques, with type III increasing markedly in proportion to type I. All four patients with Peyronie's disease in our population showed increased collagen III production, but only three showed elevated production of collagen Type I on stimulation by glyceraldehyde. There was individual variation amongst these patients' samples in regard to collagen elaboration in vitro under the present circumstances. Cavernosal tissue obtained from one patient without Peyronie's disease showed a marked increase in the elaboration of collagen III and only a slight increase in collagen Type I, while a sample from another patient showed a minimal increase in collagen I and none for collagen III. It is conceivable that some patients may have had undiagnosed early Peyronie's disease at the time of penile prosthesis implantation or are more prone to this disease. In addition, diabetes and other similar conditions which are accompanied by increased production of reactive oxygen species may play an important role in such susceptibilities to Peyronie's disease, therefore accounting for the large increase in collagen elaboration. How such in vitro data can be extrapolated to the susceptibility and pathogenesis of Peyronie's disease in an in vivo situation is debatable. However, our studies clearly indicate this in vitro system to be a viable model in understanding the role of oxygen radicals and mechanisms of collagen elaboration.
The cellular effects of oxygen radicals have been partially elucidated by similar in vitro experiments done on ®broblasts. Houglum et al 15 found that lipid peroxidation of the ®broblast cell membrane, as caused by oxygen radicals, stimulated collagen gene transcription. With the addition of a-tocopherol, an oxygen radical scavenger, collagen mRNA levels decreased and the transcriptional rate also fell, resulting in a lower amount of collagen production. Murrell et al 14 found that low concentrations of oxygen free radicals (generated by 1 ± 100 mM glyceraldehyde) stimulated cultured ®broblasts to proliferate in vitro, and high concentrations of free radicals (generated by 1000 mM glyceraldehyde) were toxic. In addition, cultured ®broblasts released their own baseline level of free radicals (measured as superoxide at 0.37 nma10 5 cells), and these endogenous radicals were inhibited when oxygen radical scavengers were added to the medium. Patients af¯icted with Peyronie's disease may have a higher baseline level of oxygen radical release, resulting in higher rates of collagen production and plaque formation. Alternatively, Peyronie's patients may be unable to suppress the increased production of oxygen radicals, possibly due to low free radical scavenging capacity. 25 This may explain why one of our samples from a patient without diagnostic Figure 3 The effect of vitamin E (2.5 mM), glyceraldehyde (Gly) (10 mM), the combination of vitamin E and glyceraldehyde, gamma-interferon (gIFN) (100 000 IUaml) and the combination of gamma interferon and glyceraldehyde, on in vitro collagen production by HCMF.
Collagen production in an in vitro model for Peyronie's disease SK Ahuja et al Peyronie's disease did not have collagen III stimulation with the addition of L-glyceraldehyde. However, in this present study, we used human cavernosal explants in primary culture, which is more related clinically to elaborate collagen expression rather than the pure ®broblast cell lines used by other investigators. 14, 15 From the studies of Houglum et al 15 we know that oxygen radicals can induce collagen gene transcription. Gamma interferon is recognized to affect synthesis of cellular products post-transcriptionally. Duncan et al 26 showed that gamma interferon can suppress collagen production in vitro. In our studies, gamma interferon showed a signi®cant suppression of collagen I and III production before and after the addition of L-glyceraldehyde. This suppression was much greater than that observed with a-tocopherol. The results of the addition of gamma interferon suggest that either it has a much greater antioxidant capacity, or the control of increased collagen production is not only under the in¯uence of oxygen radicals, but may also involve other mechanisms in the pathogenesis of Peyronie's plaques.
Along these lines, Moreland et al 27 recently demonstrated that TGF-beta induces collagen production and that this effect could in turn be inhibited by PGE 1 . There is likely more than one mechanism that can lead to the increased production of collagen in Peyronie's disease. Similarly, effective future medical treatments for this perplexing condition will likely include in¯uencing a number of different mechanisms to accomplish plaque resolution.
Conclusions
We have been able to successfully demonstrate collagen production in human cavernosal myo®bro-blasts in primary culture derived from corpus cavernosal tissue explants on stimulation with oxygen free radicals. Antioxidants like a-tocopherol can suppress this stimulation. This is one of many steps in the pathogenesis of Peyronie's disease. Vitamin E (a-tocopherol) may bene®t patients with Peyronie's disease if the plaque is in the early formation phase, or it can prevent plaque formation after known stimuli for scarring, such as trauma, have occurred. Gamma interferon, which has an effect at the post-transcriptional level, appears to have an inhibitory in¯uence on plaque formation.
